Lovedrug: Everything Starts Where It Ends debuts at #162

Press Release from The Militia Group:

Lovedrug’s sophomore album, Everything Starts Where It Ends, debuted at #162 on Billboard’s Top 200 chart, #5 on the Heatseekers chart and #2 on the Alternative New Artist chart, week of release. The band celebrated the impressive first week sales with four packed shows at the South By Southwest Music Festival, and immediately rejoined their national tour with Plain White T’s.

The band’s success has prompted Yahoo! Music to hand pick the Ohio-based quartet for its acclaimed Who’s Next online promotional campaign. The month-long, vote-driven contest, which began March 14, is showcasing the band’s video Ghost By Your Side and the album’s lead track Happy Apple Poison. Like past winners My Chemical Romance, Hawthorne Heights and fellow Militia Group label mates Cartel and Copeland, Lovedrug will be invited to Yahoo!’s Los Angeles headquarters to record an exclusive interview and a one-song performance if they take the top honors. Fans can head to http://launch.yahoo.com/promotions/whosnext to vote for the band.

Lovedrug – Ghost By Your Side
Lovedrug – Happy Apple Poison
Lovedrug – Doomsday and The Echo

Lovedrug on:
iTunes | Emusic | Insound | Amazon | Hype Machine | Elbo.ws | Musicofthe.net | Last.fm | YouTube | Flickr


  • February 15, 2008 -- Puddlegum: Sit and Stare
  • August 2, 2007 -- Rogue Wave: Asleep at Heaven’s Gate and tour with Feist
  • April 5, 2010 -- Ben Cooper of Electric President, Radical Face, and Patients
  • December 2, 2009 -- Shout Out Louds: Walls video and mp3
  • April 19, 2007 -- Iron and Wine: to release Shepherd’s Dog on September 25
  • January 23, 2007 -- Lovedrug: granted release from Columbia Records
  • September 19, 2006 -- Joseph Arthur: new album + new label
  • November 20, 2006 -- The Constantines: side projects and a winter tour
  • September 30, 2009 -- The Rest: Everyone All At Once
  • November 30, 2006 -- The Shins: The Phantom Leak
  • No Comments »

    No comments yet.

    RSS feed for comments on this post. TrackBack URL

    Leave a comment